Загрузка...
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state
13-cis-retinoic acid (RA) is typically used in post-remission maintenance therapy in patients with neuroblastoma. However, side effects and recurrence are often observed. We investigated the use of miRNAs as a strategy to replace RA as promoters of differentiation. miR-124 was identified as the top...
Сохранить в:
| Опубликовано в: : | Mol Cancer Res |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6942226/ https://ncbi.nlm.nih.gov/pubmed/31624087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0187 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|